Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females	DNA Virus Infections, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Infections, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin Diseases, Viral, Skin and Connective Tissue Diseases, Tumor Virus Infections, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, androgen insensitivity syndrome, non-human animal, anogenital human papillomavirus infection, cervix disorder, common wart, female reproductive system disorder, female reproductive system neoplasm, human papilloma virus infection, infectious disease, low grade vulvar intraepithelial neoplasia, neoplasm, sexually transmitted disease, skin disorder, skin disorder caused by infection, uterine disorder, vaginal cancer, vaginal disorder, viral infectious disease, viral sexually transmitted disease, vulva cancer, vulvar disease	Recruiting	Phase 3	2024-06-07		NCT04422366

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Shanghai Bovax Biotechnology Co., Ltd.	4

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Liuzhou center for disease control and prevention	Liuzhou	China	1